Education
About Us
Working with TipRanks
Follow Us
Sumitomo Dainippon Pharma Co Ltd (JP:4506)
:4506
RESEARCH TOOLSreports
Total Valuation
Sumitomo Dainippon Pharma Co has a market cap or net worth of $359.15B. The enterprise value is ¥985.42B.
Market Cap$359.15B
Enterprise Value¥985.42B
Share Statistics
Sumitomo Dainippon Pharma Co has 397,900,150 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding397,900,150
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Sumitomo Dainippon Pharma Co’s return on equity (ROE) is 0.14 and return on invested capital (ROIC) is 3.61%.
Return on Equity (ROE)0.14
Return on Assets (ROA)0.03
Return on Invested Capital (ROIC)3.61%
Return on Capital Employed (ROCE)0.03
Revenue Per Employee80.09M
Profits Per Employee4.75M
Employee Count4,980
Asset Turnover0.54
Inventory Turnover1.63
Valuation Ratios
The current PE Ratio of Sumitomo Dainippon Pharma Co is 12.25. Sumitomo Dainippon Pharma Co’s PEG ratio is 0.02.
PE Ratio12.25
PS Ratio0.00
PB Ratio0.79
Price to Fair Value1.71
Price to FCF-399.76
Price to Operating Cash Flow26.96
PEG Ratio0.02
Income Statement
In the last 12 months, Sumitomo Dainippon Pharma Co had revenue of 398.83B and earned 23.63B in profits. Earnings per share was 59.49.
Revenue398.83B
Gross Profit245.40B
Operating Income14.93B
Pretax Income18.52B
Net Income23.63B
EBITDA57.58B
Earnings Per Share (EPS)59.49
Cash Flow
In the last 12 months, operating cash flow was 16.50B and capital expenditures -8.50B, giving a free cash flow of 8.00B billion.
Operating Cash Flow16.50B
Free Cash Flow8.00B
Free Cash Flow per Share20.11
Dividends & Yields
Sumitomo Dainippon Pharma Co pays an annual dividend of ¥7, resulting in a dividend yield of ―
Dividend Per Share¥7
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.03
52-Week Price Change208.04%
50-Day Moving Average750.30
200-Day Moving Average662.57
Relative Strength Index (RSI)70.77
Average Volume (3m)15.35M
Important Dates
Sumitomo Dainippon Pharma Co upcoming earnings date is Jul 30, 2025, TBA Not Confirmed.
Last Earnings DateMay 13, 2025
Next Earnings DateJul 30, 2025
Ex-Dividend DateMar 30, 2023
Financial Position
Sumitomo Dainippon Pharma Co as a current ratio of 1.05, with Debt / Equity ratio of 82.29%
Current Ratio1.05
Quick Ratio0.66
Debt to Market Cap1.05
Net Debt to EBITDA4.90
Interest Coverage Ratio1.11
Taxes
In the past 12 months, Sumitomo Dainippon Pharma Co has paid -6.02B in taxes.
Income Tax-6.02B
Effective Tax Rate-0.33
Enterprise Valuation
Sumitomo Dainippon Pharma Co EV to EBITDA ratio is 9.93, with an EV/FCF ratio of 71.47.
EV to Sales1.43
EV to EBITDA9.93
EV to Free Cash Flow71.47
EV to Operating Cash Flow34.66
Balance Sheet
Sumitomo Dainippon Pharma Co has $23.12B in cash and marketable securities with ¥305.42B in debt, giving a net cash position of $282.31B billion.
Cash & Marketable Securities$23.12B
Total Debt¥305.42B
Net Cash$282.31B
Net Cash Per Share$709.49
Tangible Book Value Per Share-$504.51
Margins
Gross margin is 67.79%, with operating margin of 3.74%, and net profit margin of 5.93%.
Gross Margin67.79%
Operating Margin3.74%
Pretax Margin4.64%
Net Profit Margin5.93%
EBITDA Margin14.44%
EBIT Margin8.03%
Analyst Forecast
The average price target for Sumitomo Dainippon Pharma Co is $900.06, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$900.06
Price Target Upside-13.04% Downside
Analyst ConsensusModerate Buy
Analyst Count2
Revenue Growth Forecast26.79%
EPS Growth Forecast―